Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled randomized trial of lamivudine in acute hepatitis B
2005-005987-94Phase 2Completed
- Sponsor
- Leipzig University
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatitis B (HBV) comparing Lamivudine with Placebo (2 arms). Primary endpoint: Time until bilirubin < 2 mg/dl. Started Apr 2006; status: completed.
02
Drugs
lamivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2005-005987-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005987-94.